摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-dimethylene-1,4-dioxane | 70517-24-7

中文名称
——
中文别名
——
英文名称
2,3-dimethylene-1,4-dioxane
英文别名
2,3-dimethylene-[1,4]dioxane;2,3-Dimethylen-[1,4]dioxan;2,3-Dimethylen-1,4-dioxan;1,4-Dioxane, 2,3-bis(methylene)-;2,3-dimethylidene-1,4-dioxane
2,3-dimethylene-1,4-dioxane化学式
CAS
70517-24-7
化学式
C6H8O2
mdl
——
分子量
112.128
InChiKey
BMNHEIVPVHWGCJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:945fa1015107250e511597a3116ccbb6
查看

反应信息

  • 作为反应物:
    描述:
    2,3-dimethylene-1,4-dioxane2'-(2''-chlorocycloprop-1''-enyl)ethyl acetate四氢呋喃 为溶剂, 反应 96.0h, 生成 2'-<(3''α,5''α)-5''-chloro-8'',11''-dioxatricyclo<5.4.0.03'',5''>undec-1''(7'')-en-3''-yl>ethyl acetate
    参考文献:
    名称:
    Banwell, Martin G.; Corbett, Madelaine; Gulbis, Jacqueline, Journal of the Chemical Society. Perkin transactions I, 1993, # 8, p. 945 - 964
    摘要:
    DOI:
  • 作为产物:
    描述:
    cis-2,3-bis(iodomethyl)-1,4-dioxane 在 sodium hydroxide二乙二醇乙醚 作用下, 生成 2,3-dimethylene-1,4-dioxane
    参考文献:
    名称:
    A New Synthesis and the Stereochemistry of Some 2,3-Disubstituted Dioxanes
    摘要:
    DOI:
    10.1021/ja01571a069
点击查看最新优质反应信息

文献信息

  • Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof
    申请人:Dana-Farber Cancer Institute, Inc.
    公开号:US10000483B2
    公开(公告)日:2018-06-19
    The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the compounds of Formula (I) or (II), or compositions thereof, for treating or preventing a wide range of diseases (e.g., proliferative diseases (e.g., cancers, benign neoplasms, angiogenesis, inflammatory diseases, autoimmune diseases) and metabolic diseases (e.g., diabetes (e.g., type 2 diabetes, gestational diabetes)) in a subject. Treatment of a subject with a disease using a compound of Formula (I) or (II), or compositions thereof, may downregulate the expression and/or inhibit the activity of a kinase (e.g., a tyrosine kinase, such as a Tec kinase, in particular, bone marrow on X chromosome kinase (BMX)), and therefore, suppress tyrosine kinase singling in the subject.
    本发明提供了新颖的式(I)化合物及其药学上可接受的盐、溶液剂、水合物、多晶型、共晶体、同系物、立体异构体、同位素标记的衍生物、原药及其组合物。还提供了涉及式(I)或(II)化合物或其组合物的方法和试剂盒,用于治疗或预防受试者的多种疾病(如增殖性疾病(如癌症、良性肿瘤、血管生成、炎症性疾病、自身免疫性疾病)和代谢性疾病(如糖尿病(如 2 型糖尿病、妊娠糖尿病))。使用式(I)或(II)化合物或其组合物治疗患有疾病的受试者,可下调激酶(如酪氨酸激酶,如Tec激酶,特别是X染色体上的骨髓激酶(BMX))的表达和/或抑制其活性,从而抑制受试者体内的酪氨酸激酶单体。
  • BONE MARROW ON X CHROMOSOME KINASE (BMX) INHIBITORS AND USES THEREOF
    申请人:DANA-FARBER CANCER INSTITUTE, INC.
    公开号:US20150246913A1
    公开(公告)日:2015-09-03
    The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the compounds of Formula (I) or (II), or compositions thereof, for treating or preventing a wide range of diseases (e.g., proliferative diseases (e.g., cancers, benign neoplasms, angiogenesis, inflammatory diseases, autoimmune diseases) and metabolic diseases (e.g., diabetes (e.g., type 2 diabetes, gestational diabetes)) in a subject. Treatment of a subject with a disease using a compound of Formula (I) or (II), or compositions thereof, may downregulate the expression and/or inhibit the activity of a kinase (e.g., a tyrosine kinase, such as a Tec kinase, in particular, bone marrow on X chromosome kinase (BMX)), and therefore, suppress tyrosine kinase singling in the subject.
  • PHOTOELECTRIC CONVERSION ELEMENT AND METHOD OF MANUFACTURING PHOTOELECTRIC CONVERSION ELEMENT
    申请人:SONY CORPORATION
    公开号:US20210193740A1
    公开(公告)日:2021-06-24
    A first photoelectric conversion element according to an embodiment of the present disclosure incudes: a first electrode; a second electrode disposed to be opposed to the first electrode; and a photoelectric conversion layer provided between the first electrode and the second electrode and including a chromophore, fullerene or a fullerene derivative, and a hole-transporting material, in which the chromophore and the fullerene or the fullerene derivative are bonded to each other at least partially via a crosslinking group in the photoelectric conversion layer.
  • US7279200B2
    申请人:——
    公开号:US7279200B2
    公开(公告)日:2007-10-09
  • US9316631B1
    申请人:——
    公开号:US9316631B1
    公开(公告)日:2016-04-19
查看更多

同类化合物

(2S,4aR,5S,8R,8aR)-8-乙基-4a,5-二羟基-六氢-2H-2,5-环氧色素-4(3H)-酮 阿斯利多 锗(II)氯化二噁烷络合物 试剂5-Methyl-5-propargyloxycarbonyl-1,3-dioxane-2-one 螺二醇 螺[环丙烷-1,7'-[2,3]二氧杂双环[2.2.1]庚烷] 螺[3,6-二氧杂双环[3.1.0]己烷-2,4'-咪唑烷] 薰衣草恶烷 苯乙醛 1,3-丙烷二基缩醛 脱水莫诺苷元 硫脲与2,4,8,10-四氧杂螺[5.5]十一烷-3,9-丙二胺和缩水甘油丁醚的反应产物 硝溴生 盐酸大观霉素 盐酸1,4-二恶烷 甲基 2,3-脱水-beta-D-呋喃核糖苷 甘油缩甲醛 溴化[5-(羟甲基)-2-苯基-1,3-二噁烷-5-基]-N,N,N-三甲基甲铵 溴[4-(1,3-二恶烷-2-基)苯基]镁 溴[3-(1,3-二恶烷-2-基)苯基]镁 溴[2-(1,3-二恶烷-2-基)苯基]镁 溴-1,4-二氧六环复合物 氯甲基聚苯乙烯 敌噁磷 戊氧氯醛 对二恶烷-2,6-二甲醇 奇烯醇霉素 大观霉素 埃玛菌素 吡啶,2-(1,3-二噁烷-2-基)- 反式-5-溴-4-苯基-[1,3]二恶烷 反式-2,5-双-(羟甲基)-1,4-二恶烷 双(4-乙基亚苯基)山梨醇 六氢[1,4]二恶英并[2,3-b]-1,4-二恶英 六氢-2,4,4,7-四甲基-4H-1,3-苯并二氧杂环己 全氟(2-氧代-3,6-二甲基-1,4-二恶烷) 亚苄基-2,2-双(氧基甲基)丙酸 二苯并[b,e][1,4]二噁英,4a,5a,9a,10a-四氢-,溴化氯化(1:2:6) 二苯并[b,e][1,4]二噁英,4a,5a,9a,10a-四氢-,溴化氯化(1:2:5) 二聚丁醇醛 二甲基二恶烷 二甲基2,4:3,5-二-O-亚甲基-D-葡萄糖二酸 二甲基2,4,8,10-四氧杂螺[5.5]十一烷-3,9-二羧酸酯 二甲基-1,4-二恶烷 二甘醇酐 二环[3.1.0]己烷-3-酮,4-亚甲基-1-(1-甲基乙基)-,肟 二氯硼烷二氧六环 二氧六环-d8 二氢壮观霉素 二恶烷 二噁烷甘醇